Literature DB >> 28656643

Risk factors for medication-related osteonecrosis of the jaws: A systematic review.

K McGowan1, T McGowan1, S Ivanovski2.   

Abstract

The purpose of this study was to identify the patient populations at risk of medication-related osteonecrosis of the jaw (MRONJ) and determine which medical and dental comorbidities are significant risk factors for this disease. An electronic search of Embase, MEDLINE, Cochrane Central Register of Controlled Trials, WHO International Clinical Trials Registry Platform and ProQuest Dissertations and Theses Global was conducted to identify all human studies that reported risk factors for MRONJ. Only a qualitative analysis was performed due to significant heterogeneity in the collected data. The search strategy identified 2872 records, of which 219 studies were eligible for inclusion. A total of 4106 patients with MRONJ were identified, 39 different systemic diseases were implicated, and 14 medical and 11 dental risk factors were reported, although no statistical analysis of the significance of each of these factors was possible. The clinical reach of MRONJ may be wider than anticipated, and more data on the significance of each potential risk factor are needed to guide the identification and management of at-risk patients.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  anti-neoplastic agents; bone density conservation agents; cancer; molecular targeted therapy; osteoporosis; preventative dentistry

Mesh:

Year:  2017        PMID: 28656643     DOI: 10.1111/odi.12708

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  31 in total

1.  Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw.

Authors:  Sara de Cassia Tornier; Fernanda Joly Macedo; Laurindo Moacir Sassi; Juliana Lucena Schussel
Journal:  Support Care Cancer       Date:  2021-05-10       Impact factor: 3.603

2.  Authors' reply: Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.

Authors:  Boon Hui Chan; Ruixiang Yee; Rukshini Puvanendran; Seng Bin Ang
Journal:  Singapore Med J       Date:  2018-05       Impact factor: 1.858

3.  Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.

Authors:  Akishige Hokugo; Keiichi Kanayama; Shuting Sun; Kenzo Morinaga; Yujie Sun; QingQing Wu; Hodaka Sasaki; Hiroko Okawa; Courtney Evans; Frank H Ebetino; Mark W Lundy; Keivan Sadrerafi; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2019-03-26       Impact factor: 4.398

Review 4.  Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.

Authors:  L Dos Santos Ferreira; L G Abreu; C B Calderipe; M D Martins; L F Schuch; A C U Vasconcelos
Journal:  Osteoporos Int       Date:  2021-07-31       Impact factor: 4.507

5.  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Authors:  Ourania Nicolatou-Galitis; Maria Kouri; Erofili Papadopoulou; Emmanouil Vardas; Dimitra Galiti; Joel B Epstein; Sharon Elad; Giuseppina Campisi; Nikolaos Tsoukalas; Kivanc Bektas-Kayhan; Winston Tan; Jean-Jacques Body; Cesar Migliorati; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2018-10-23       Impact factor: 3.603

Review 6.  Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.

Authors:  Mampei Kawahara; Shinichiro Kuroshima; Takashi Sawase
Journal:  Int J Implant Dent       Date:  2021-05-14

Review 7.  Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes.

Authors:  Marianne Lamarre; Martine Marcotte; Danielle Laurin; Daniela Furrer; Isabelle Vedel; André Tourigny; Anik Giguère; Pierre-Hugues Carmichael; Rosa Martines; José Morais; Edeltraut Kröger
Journal:  Arch Osteoporos       Date:  2021-09-15       Impact factor: 2.617

Review 8.  Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.

Authors:  Athanasios D Anastasilakis; Jessica Pepe; Nicola Napoli; Andrea Palermo; Christos Magopoulos; Aliya A Khan; M Carola Zillikens; Jean-Jacques Body
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

Review 9.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

Review 10.  Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).

Authors:  Sven Otto; Suad Aljohani; Riham Fliefel; Sara Ecke; Oliver Ristow; Egon Burian; Matthias Troeltzsch; Christoph Pautke; Michael Ehrenfeld
Journal:  Medicina (Kaunas)       Date:  2021-05-09       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.